Varenicline is a partial agonist at a4ß2 and a full agonist at a7 neuronal nicotinic receptors

K Mihalak; F Carroll; C Luetje

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Varenicline is a partial agonist at a4ß2 and a full agonist at a7 neuronal nicotinic receptors

Mihalak, K., Carroll, F., & Luetje, C. (2006). Varenicline is a partial agonist at a4ß2 and a full agonist at a7 neuronal nicotinic receptors. Molecular Pharmacology, 70(3), 801 - 805.

Copy citation

Recent Publications

METHODS REPORT

Improving text classification with Boolean retrieval for rare categories

Article

COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray

Article

A decentralized approach to model national and global food and land use systems

Article

Varenicline is a partial agonist at a4ß2 and a full agonist at a7 neuronal nicotinic receptors

Publications Info

Recent Publications

Improving text classification with Boolean retrieval for rare categories

COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray

A decentralized approach to model national and global food and land use systems

Use of a web-based portal to return normal individual research results in Early Check

Partner With Us

Site